Correlation of Secondary Hyperparathyroidism with Chronic Kidney Disease and its Stages
To study the prevalence of secondary hyperparathyroidism in chronic kidney disease. To measure serum intact parathormone levels in chronic kidney disease patients aged more than 20 years, attending SBMCH, Chennai. To associate increased parathormone levels with the different stages of chronic kidney disease in these patients. In this study, the results are statistically significant indicating that there is enough evidence to suggest that patients with CKD stage IV and V are at 8.6 times higher risk of having increased serum iPTH levels and the prevalence of secondary hyperparathyroidism increased as the stage of CKD increases. Serum iPTH is a worthwhile tool in assessing secondary hyperparathyroidism in patients with CKD.